PDUFA – 20 Disease Meeting followup … Firestorm – not!
Thank you all for your response to my recent request to send letters to the FDA on the Patient-Focused Drug Development initiative last week. Quite a number of you (dozens) responded on behalf of rare disease in general and many on behalf of MLD or lysosomal disease specifically. As I mentioned in my prior post, […]
PDUFA – 20 Disease Meeting followup … Firestorm – not! Read More »